Kevin Lee Freeman - Mar 1, 2023 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role
Chief Commercial Officer
Signature
/s/Daniel Orenstein, as Attorney-in-Fact
Stock symbol
HCAT
Transactions as of
Mar 1, 2023
Transactions value $
-$22,419
Form type
4
Date filed
3/3/2023, 04:09 PM
Previous filing
Dec 5, 2022
Next filing
Jun 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCAT Common Stock Tax liability -$22.4K -1.57K -0.87% $14.29 178K Mar 1, 2023 Direct F1
transaction HCAT Common Stock Award $0 +1.82K +1.02% $0.00 180K Mar 1, 2023 Direct F2
transaction HCAT Common Stock Award $0 +1.26K +0.7% $0.00 181K Mar 1, 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F2 Represents an award of 1,819 performance-based restricted units ("PRSUs") pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each PRSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2022, the PRSUs noted above vested on March 1, 2023.
F3 Represents an award of 1,264 PRSUs pursuant to the 2019 Plan. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2022, 25% of the PRSUs noted above vested on March 1, 2023 and, thereafter, the remaining 75% of the PRSUs will vest in 12 equal quarterly installments.